methylprednisolone has been researched along with Pityriasis Rubra Pilaris in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Canavan, T; Doan, LT; Ricardo-Gonzalez, RR; Rosenblum, MD; Shen, G; Sidorsky, T | 1 |
Brzezińska-Wcisło, L; Krauze, E; Lis-Swiety, A; Wcisło-Dziadecka, D | 1 |
2 other study(ies) available for methylprednisolone and Pityriasis Rubra Pilaris
Article | Year |
---|---|
A case of Wong-type dermatomyositis with concomitant anti-MDA5 features.
Topics: Biomarkers; Biopsy, Needle; DEAD-box RNA Helicases; Dermatomyositis; Drug Therapy, Combination; Electromyography; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Gene Expression Regulation; Humans; Hydroxychloroquine; Immunohistochemistry; Interferon-Induced Helicase, IFIH1; Male; Methylprednisolone; Middle Aged; Mycophenolic Acid; Pityriasis Rubra Pilaris; Rare Diseases; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2014 |
[Diagnostic and therapeutic difficultes in pityriasis rubra pilaris--case report].
Topics: Acitretin; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Carbonate; Cefuroxime; Chronic Disease; Diagnosis, Differential; Drug Therapy, Combination; Histamine H2 Antagonists; Humans; Hydroxycholecalciferols; Keratolytic Agents; Male; Methylprednisolone; Middle Aged; Pityriasis Rubra Pilaris; Ranitidine | 2005 |